<DOC>
	<DOCNO>NCT02127398</DOCNO>
	<brief_summary>It show restoration normal makeup bowel bacterial population effective way treat recurrent colitis due Clostridium difficile . Restoration normal bowel bacterial population best do transplant stool healthy donor . The investigator wish transplant stool healthy donor treat recurrent C. difficile colitis incorporate stool capsule administer oral route .</brief_summary>
	<brief_title>Stool Transplants Treat Refractory Clostridium Difficile Colitis</brief_title>
	<detailed_description>Recurrent colitis due Clostridium difficile result disruption normal gut flora , difficult treat . It clear restoration normal gut flora effective way treat recurrent C. difficile colitis . Restoration normal gut flora best do transplant stool healthy donor , accept superior therapeutic modality recurrent C. difficile colitis . This fecal microbiota transplantation do direct instillation donor stool GI tract via naso-duodenal tube colonoscope . Recently , non-invasive method stool transplantation develop donor stool encapsulate administer pill form . The investigator would like use fecal microbiota transplantation encapsulate stool non-invasive therapy patient recurrent C. difficile colitis . To qualify , patient must history , least , 3 episode C difficile colitis within past year , least , 2 episode C difficile colitis result hospitalization . Stool sample obtain healthy volunteer screen infection transmit via stool , investigator prepare capsule contain processed stool administration single outpatient clinic visit . Patients follow closely administration fecal transplant serial clinic visit , primary endpoint prevention episodes C. difficile colitis six month period follow transplantation . The investigator also obtain store stool sample patient fecal microbiota transplantation possible future microbiome analysis . The obvious safety concern transmission infection donor . All donor carefully screen high-risk exposure undergo test blood stool ensure free infection due HIV , acute hepatitis A , acute/chronic hepatitis B , hepatitis C , giardiasis , cryptosporidiosis , Helicobacter pylorus .</detailed_description>
	<mesh_term>Colitis</mesh_term>
	<criteria>Study entry open adult ( &gt; 18 year old ) three episode Clostridium difficile colitis within previous 12 month . Absolute neutrophil count &lt; 500 cells/mm3 Active infection site ( exclude Clostridium difficile ) require ongoing antibacterial therapy ( antiviral antifungal therapy acceptable ) Current plan cytotoxic chemotherapy within 14 day potential fecal transplantation date Life expectancy &lt; 180 day Diagnosis inflammatory bowel disease ( e.g . Crohn 's ulcerative colitis ) Inability swallow capsule Indwelling nasogastric , orogastric , gastrostomy , jejunostomy tube History partial total gastrectomy Short gut syndrome require total parenteral nutrition Pregnancy Documented intestinal parasite infection without documentation appropriate treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>C. difficile colitis</keyword>
	<keyword>fecal microbiota transplantation</keyword>
</DOC>